Category Archives: Research

06Jan/22

New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Results from a newly released survey provide insights from adults living with bipolar I disorder (BD-I)* in the United States (U.S.) on the burden of living with this serious mental health condition and their experiences with treatment. This research was conducted in support of Alkermes’ commitment to understanding the unique needs of people living with BD-I and supporting increased disease awareness and education. Continue reading

04Dec/21

GreenLight (ENVI) and IAVI begin work on Omicron variant-adapted COVID-19 vaccine candidate

GreenLight Biosciences (ENVI) and IAVI, a nonprofit scientific research organization, today announced work on a messenger RNA vaccine candidate to tackle the COVID-19 Omicron variant. Continue reading

08Nov/21

As Winter Draws Near, Research Reveals That Fruit Juice Is One Of Top Three Foods For Immune Function

A poll of more than 3000 adults, commissioned by the Fruit Juice Science Centre, has found that two thirds of Brits (65%) and more than a third of French and German adults (34%) drink 100% fruit juice to support their immune function. The beverage was most frequently listed after fruit and vegetables amongst the top immunity-support foods. Continue reading

20Sep/21

Appealing Data of CARsgen Therapeutics’ CAR-T (CT041) in Advanced Gastric Cancer Presented at ESMO

On September 19, 2021, CARsgen Therapeutics (stock code: 2171.HK) disclosed the latest progress of the investigator-initiated trial (IIT) of Claudin18.2 (CLDN18.2) CAR-T (CT041) for the treatment of digestive system tumors. Results of this trial have been orally presented at the European Society of Medical Oncology Congress 2021 (ESMO 2021). The presenter was Dr. Changsong Qi from Beijing Cancer Hospital. Continue road

20Sep/21

University of Oxford and Oracle Cloud System Helping Researchers Identify COVID-19 Variants Faster

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Continue reading

10Sep/21

Preventing the Long-Term Effects of Traumatic Brain Injury

You’ve been in a car accident and sustained a head injury. You recovered, but years later you begin having difficulty sleeping. You also become very sensitive to noise and bright lights, and find it hard to carry out your daily activities, or perform well at your job. This is a common situation after a traumatic brain injury—many people experience bad side effects months or years later. These long-term effects can last a few days or the rest of a person’s life. Read more

17Aug/21

COVID-19’s Vaccine and Drug Innovators Chosen as Recipients of the Galien Foundation 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity

The Prix Galien Awards Committee announced today that six world-leading biopharma companies responsible for development of COVID-19 vaccines and therapeutics will jointly receive the 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity at the 15th annual Prix Galien USA Awards Ceremony, to be held on Thursday, October 28, at the American Museum of Natural History in New York City. Continue reading

11Jul/21

Genetic factors linked to response to common antiviral medications

St. Jude Children’s Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir. The researchers showed that NUDT15 status can help predict how individuals will respond to treatment for cytomegalovirus, a serious infection common among people who receive bone marrow transplants. The paper was published today in Nature Communications. Continue reading

28May/21

Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25

The most comprehensive data on global trends in smoking highlight its enormous global health toll. The number of smokers worldwide has increased to 1.1 billion in 2019, with tobacco smoking causing 7.7 million deaths – including 1 in 5 deaths in males worldwide. Continue reading

27May/21

As India Burns Amid a Lethal 2nd Wave, It’s Now Evident that the World Has Failed in Ensuring Equitable Access to Vaccines. While Vaccine Doses Reach 9.7 Billion by 2025, Will They be Equitably Distributed?

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released the 1st edition of its report titled “COVID-19 Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on what to expect post commercialization of COVID-19 vaccines amid the rising spirit of vaccine nationalism, selfish international politics over vaccines, inadequate market access, stockpiling, and vaccine patents that still remain firmly in place. Continue reading